InsiderTrades

Form 4 for WGS GeneDx Holdings Corp.

Accepted 2023-01-04 00:00:00 ET · period of report 2023-01-01 · accession 0001209191-23-001448 · SEC index · Original document

Summary rows

Aggregated the way they appear in lists: one row per insider, transaction code and security table.

X Filed Traded Ticker Insider Title Type Price Qty Owned ΔOwn Value
D 2023-01-04 2023-01-01 WGS Saad Kareem Chief Transformation Off M - OptEx — +9,005 104.9K +9% —
D 2023-01-04 2023-01-01 WGS Saad Kareem Chief Transformation Off M - OptEx $0.00 -9,005 126.1K -7% $0

Purchase Sale Sale after option exercise All abbreviations

Every reported transaction

#TableSecurityDateCodeA/DSharesPriceOwned afterOwnExercise / expiryUnderlyingFootnotes
1 Common Class A Common Stock 2023-01-01 M A 9,005 — 104,935 D — — (F1) Each restricted stock unit ("RSU") represents a contingent right to receive 1 share of the Issuer's Class A Common Stock upon settlement for no consideration.
2 Derivative Restricted Stock Unit 2023-01-01 M D 9,005 $0.00 126,076 D — · — to — 9,005 Class A Common Stock (F1) Each restricted stock unit ("RSU") represents a contingent right to receive 1 share of the Issuer's Class A Common Stock upon settlement for no consideration. (F2) 6.25% vest in quarterly installments over the 4-year period on April 4, 2022 until fully vested, subject to the Reporting Person's continued service to the Issuer on each vesting date